EXANE DERIVATIVES - SEAGEN INC ownership

SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of SEAGEN INC
ValueSharesWeighting
Q2 2022$152,845,000
-27.9%
864
-41.3%
0.09%
+46.7%
Q1 2022$211,884,000
-17.7%
1,471
-11.7%
0.06%
-3.2%
Q4 2021$257,400,000
-19.4%
1,665
-11.4%
0.06%
-19.5%
Q3 2021$319,213,000
+13.7%
1,880
-3.7%
0.08%
+20.3%
Q2 2021$280,847,000
-11.7%
1,952
-14.8%
0.06%
-29.7%
Q1 2021$318,114,000
-40.1%
2,291
-24.4%
0.09%
-41.7%
Q4 2020$530,825,0003,0310.16%
Other shareholders
SEAGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Baker Brothers Advisors 46,912,266$8,300,656,00047.09%
Eagle Health Investments LP 262,502$46,447,00010.83%
EcoR1 Capital, LLC 1,008,628$178,467,0006.16%
Lagoda Investment Management, L.P. 49,460$8,751,0005.80%
Redmile Group, LLC 854,013$151,109,0005.77%
Nan Fung Group Holdings Ltd 47,096$8,333,0005.72%
Atika Capital Management LLC 282,500$49,985,0005.62%
Avoro Capital Advisors LLC 1,525,000$269,834,0005.33%
Parkman Healthcare Partners LLC 76,626$13,558,0004.99%
Artal Group S.A. 525,000$92,894,0004.96%
View complete list of SEAGEN INC shareholders